UCT Revenue and Competitors

Location

N/A

Total Funding

Chemicals

Industry

Estimated Revenue & Valuation

  • UCT's estimated annual revenue is currently $15M per year.(i)
  • UCT's estimated revenue per employee is $154,639

Employee Data

  • UCT has 97 Employees.(i)
  • UCT grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M180%N/AN/A
#2
$1700M36153%N/AN/A
#3
$7.5M710%N/AN/A
#4
$1180M25715%N/AN/A
#5
$3.5M467%N/AN/A
#6
$7.5M51-19%N/AN/A
#7
$7.5M12-20%N/AN/A
#8
N/A274%N/AN/A
#9
$7.5M330%N/AN/A
#10
N/A90%N/AN/A
Add Company

What Is UCT?

United Chemical Technologies was founded in Horsham, PA in 1986. Since then, UCT has evolved into a major competitor in the field of silica-based solid phase extraction. In October 1993, UCT acquired the specialty chemical branch of Huls America (Petrarch). This expansion into silane manufacturing allows for greater control over the chemical processes involved in producing our high-quality bonded phases. At UCT, we are committed to creating the highest quality products and distinguishing ourselves by the service, from salesperson to technical support, that we provide to every customer. As our company has grown over the past three decades, our solid phase product offerings have expanded as well. Every product that UCT makes, from columns to well plates, QuEChERS, polymeric based SPE, derivatizing reagents, GC liners, and manifolds are manufactured to the highest standards. We now offer hydrolyzing enzymes and HPLC Columns, and we have developed products for the cannabis industry that include pesticide and purity testing. Our diverse product offerings, dedicated staff, and loyal customers have made UCT what it is today. Now, we focus on the future and another successful 30 years!

keywords:N/A

N/A

Total Funding

97

Number of Employees

$15M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.6M9735%N/A
#2
$17.1M989%N/A
#3
N/A98100%N/A
#4
$27.2M9918%N/A
#5
$75M990%N/A